For the quarter ending 2026-03-31, MRKR has $17,434,008 in assets. $3,638,050 in debts. $14,915,519 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 14,915,519 | 16,068,048 | 17,589,978 | 10,461,971 |
| Restricted cash | 723,136 | 974,799 | 1,352,975 | 1,352,975 |
| Prepaid expenses and deposits | - | 658,750 | 1,126,724 | 1,278,589 |
| Prepaid expenses and other current assets | 418,053 | - | - | - |
| Other receivables | 1,377,300 | 1,369,400 | 1,665,153 | 1,674,335 |
| Total current assets | 17,434,008 | 19,070,997 | 21,734,830 | 14,767,870 |
| Total assets | 17,434,008 | 19,070,997 | 21,734,830 | 14,767,870 |
| Deferred revenue | - | 974,799 | 1,352,975 | 1,352,975 |
| Accounts payable and accrued liabilities | 1,913,685 | 1,299,384 | 1,664,647 | 2,267,871 |
| Related party payable | 1,001,229 | - | 328,315 | 656,631 |
| Deferred grant income | 723,136 | - | - | - |
| Total current liabilities | 3,638,050 | 2,274,183 | 3,345,937 | 4,277,477 |
| Total liabilities | 3,638,050 | 2,274,183 | 3,345,937 | 4,277,477 |
| Common stock, 0.001 par value, 30 million shares authorized, 16.7 million shares issued and outstanding as of march 31, 2026 and december 31, 2025 (see note 8) | 16,672 | 16,672 | 16,672 | 11,313 |
| Additional paid-in capital | 476,139,362 | 475,960,940 | 475,849,809 | 465,958,006 |
| Accumulated deficit | -462,360,076 | -459,180,798 | -457,477,588 | -455,478,926 |
| Total stockholders' equity | 13,795,958 | 16,796,814 | 18,388,893 | 10,490,393 |
| Total liabilities and stockholders' equity | 17,434,008 | 19,070,997 | 21,734,830 | 14,767,870 |
Marker Therapeutics, Inc. (MRKR)
Marker Therapeutics, Inc. (MRKR)